Literature DB >> 19285393

Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors.

Mark A Seefeld1, Meagan B Rouse, Kenneth C McNulty, Lihui Sun, Jizhou Wang, Dennis S Yamashita, Juan I Luengo, Shuyun Zhang, Elisabeth A Minthorn, Nestor O Concha, Dirk A Heerding.   

Abstract

A pyrrolopyridinyl thiophene carboxamide 7 was discovered as a tractable starting point for a lead optimization effort in an AKT kinase inhibition program. SAR studies aided by a co-crystal structure of 7 in AKT2 led to the identification of AKT inhibitors with subnanomolar potency. Representative compounds showed antiproliferative activity as well as inhibition of phosphorylation of the downstream target GSK3beta.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285393     DOI: 10.1016/j.bmcl.2009.02.094

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape.

Authors:  Margrith E Mattmann; Sydney L Stoops; Craig W Lindsley
Journal:  Expert Opin Ther Pat       Date:  2011-06-02       Impact factor: 6.674

2.  Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.

Authors:  Priya Mahajan; Bhumika Wadhwa; Manas Ranjan Barik; Fayaz Malik; Amit Nargotra
Journal:  Mol Divers       Date:  2019-02-23       Impact factor: 2.943

3.  EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.

Authors:  Susanne Scheipl; Michelle Barnard; Lucia Cottone; Mette Jorgensen; David H Drewry; William J Zuercher; Fabrice Turlais; Hongtao Ye; Ana P Leite; James A Smith; Andreas Leithner; Peter Möller; Silke Brüderlein; Naomi Guppy; Fernanda Amary; Roberto Tirabosco; Sandra J Strauss; Nischalan Pillay; Adrienne M Flanagan
Journal:  J Pathol       Date:  2016-05-31       Impact factor: 7.996

4.  Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt).

Authors:  Tatiana McHardy; John J Caldwell; Kwai-Ming Cheung; Lisa J Hunter; Kevin Taylor; Martin Rowlands; Ruth Ruddle; Alan Henley; Alexis de Haven Brandon; Melanie Valenti; Thomas G Davies; Lynsey Fazal; Lisa Seavers; Florence I Raynaud; Suzanne A Eccles; G Wynne Aherne; Michelle D Garrett; Ian Collins
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

Review 5.  Drug Discovery of Plausible Lead Natural Compounds That Target the Insulin Signaling Pathway: Bioinformatics Approaches.

Authors:  Siba Shanak; Najlaa Bassalat; Ahmad Barghash; Sleman Kadan; Mahmoud Ardah; Hilal Zaid
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-20       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.